Hims & Hers Health (NYSE:HIMS) and 1Life Healthcare (NASDAQ:ONEM) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, institutional ownership and valuation.
Volatility & Risk
Hims & Hers Health has a beta of -0.11, meaning that its stock price is 111% less volatile than the S&P 500. Comparatively, 1Life Healthcare has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500.
27.4% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 83.9% of 1Life Healthcare shares are owned by institutional investors. 43.7% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
This table compares Hims & Hers Health and 1Life Healthcare’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Hims & Hers Health||N/A||-36.18%||-11.55%|
This is a summary of recent ratings and target prices for Hims & Hers Health and 1Life Healthcare, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Hims & Hers Health||0||4||4||0||2.50|
Hims & Hers Health currently has a consensus price target of $16.33, indicating a potential upside of 27.11%. 1Life Healthcare has a consensus price target of $47.81, indicating a potential upside of 40.75%. Given 1Life Healthcare’s stronger consensus rating and higher possible upside, analysts clearly believe 1Life Healthcare is more favorable than Hims & Hers Health.
Earnings and Valuation
This table compares Hims & Hers Health and 1Life Healthcare’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Hims & Hers Health||$148.76 million||16.57||-$40.27 million||($0.23)||-55.87|
|1Life Healthcare||$380.22 million||12.28||-$88.72 million||($0.67)||-50.70|
Hims & Hers Health has higher earnings, but lower revenue than 1Life Healthcare. Hims & Hers Health is trading at a lower price-to-earnings ratio than 1Life Healthcare, indicating that it is currently the more affordable of the two stocks.
1Life Healthcare beats Hims & Hers Health on 9 of the 14 factors compared between the two stocks.
About Hims & Hers Health
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
About 1Life Healthcare
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2020, it had approximately 549,000 members in 13 markets in the United States; and 8,000 enterprise clients. The company was incorporated in 2002 and is headquartered in San Francisco, California.
Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.